Skip to content

Functional axillary lymph node dissection for breast cancer: a prospective randomized clinical trial

Functional axillary lymph node dissection for breast cancer: a prospective randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014247
Enrollment
Unknown
Registered
2018-01-01
Start date
2018-01-01
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cacer

Interventions

1:functional axillary lymph node dissection
2:standard axillary lymph node dissection

Sponsors

Zhongnan Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged between 18 and 80 years; 2. Patients were diagnosed with breast cancer; 3. Patients agreed to participate in the study.

Exclusion criteria

Exclusion criteria: Elderly patients with breast cancer did not undergo axillary lymph node dissection.

Design outcomes

Primary

MeasureTime frame
Incidence of complications and locoregional recurrence after functional axillary lymph node dissection;Incidence of complications and locoregional recurrence after standard axillary lymph node dissection;

Secondary

MeasureTime frame
functional level of the breast lymph nodes;number of the breast lymph nodes of each level;number of the arm lymph nodes;incidence of the arm lymph nodes metastasis;crossover between the breast and arm lymph nodes;

Countries

China

Contacts

Public ContactGaosong Wu

Zhongnan Hospital of Wuhan University

wugaosongtj@163.com+86 027-67812535

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 23, 2026